<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) June 16, 1998
------------------------------
EVENFLO & SPALDING HOLDINGS CORPORATION
- -------------------------------------------------------------------------------
(Exact Name of Registrant as Specified in Its Charter)
DELAWARE 333-14569 59-2439656
- -------------------------------------------------------------------------------
(State or Other Jurisdiction of Commission (I.R.S. Employer
Incorporation or Organization) File Number Identification No.)
601 South Harbour Island Boulevard, Suite 200, Tampa, Florida 33602-3141
- -------------------------------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
Registrant's Telephone Number, Including Area Code: (813) 204-5200
---------------------------
1
<PAGE> 2
Item 5. Other Events.
Evenflo & Spalding Holdings Corporation announced on June 16, 1998, that it has
named Richard W. Frank to the newly created position of Chairman and Chief
Executive Officer of Evenflo Company, Inc. Mr. Frank has served since 1996 as
President USA and General Manager of Consumer OTC Health Care, a division of
Bayer Corporation. George A. Harris will remain President of Evenflo.
2
<PAGE> 3
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
Evenflo & Spalding Holdings Corporation
(Registrant)
Date: June 26, 1998 By: /s/ W. Michael Kipphut
------------------------------------
W. Michael Kipphut
Vice President and Treasurer
(a Principal Financial Officer and
authorized signatory)
3
